This volume brings together the work of leading medical chemists and represents efforts on the part of drug designers to produce small molecules aimed at preventing or treating brain-related diseases. Prominent among these are contributions on agents of value in Alzheimer's therapy; anxioselective anxiolytics; novel antipsychotics and the activation of dopamine autoreceptors; the role of the neurotransmitter dopamine in cocaine addiction; multiple populations of serotonin receptors; designing specific 5-HT3 receptor antagonists; glutamatergic receptor modulation; developing compounds capable of interacting with second messenger systems; and brain targeting of biologically active compounds. Also featured are examples of computer-assisted molecular modelling (CAMM) described throughout the text.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : PsychoBabel & Skoob Books, Didcot, Royaume-Uni
Hardcover. Etat : Very Good. 1st Edition. Hardcover, no jacket; printed boards, first edition; first printing, very good condition. A very clean copy overall with only minor compression to the spine ends. Internally excellent throughout. DP. Used. N° de réf. du vendeur 513413
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
hardcover. Etat : Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82907817006125
Quantité disponible : 1 disponible(s)